Jerad G. Seurer - 05 Mar 2025 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role: Gen. Counsel & Corp. Secretary
Signature: /s/ Jerad G. Seurer
Issuer symbol: AVDL
Transactions as of: 05 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2025, 16:09:00 UTC
Previous filing: 03 May 2024
Next filing: 12 Feb 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVDL	Ordinary Shares	Award	$0	+14,700	+167%	$0.000000	23,495	05 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVDL	Stock Option (Right to Buy)	Award	$0	+84,000		$0.000000	84,000	05 Mar 2025	Ordinary Shares	84,000	$7.87	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of a restricted share award. The restricted share award shall vest in equal annual installments on each of the first four anniversaries following the 3/5/2025 grant date.
F2	The options shall vest, if at all, in four equal increments if the volume-weighted average price of the Issuer's Ordinary Shares during any 30 calendar day period exceeds $11, $14, $17 and $19.09, respectively.